Immunic, Inc. (IMUX)

NASDAQ

Quick facts

TickerIMUX (NASDAQ)

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: